Please login to the form below

Not currently logged in
Email:
Password:

meningococcal B disease

This page shows the latest meningococcal B disease news and features for those working in and with pharma, biotech and healthcare.

Pfizer wins EU approval for MenB vaccine Trumenba

Pfizer wins EU approval for MenB vaccine Trumenba

The EU approval comes two-and-a-half years after Trumenba was green-lighted by the US FDA to prevent invasive meningococcal disease caused by Neisseria meningitides serogroup B, which is ... It is important to have multiple tools at our disposal to

Latest news

  • Pfizer posts positive Trumenba vaccine data Pfizer posts positive Trumenba vaccine data

    Pfizer's Trumenba vaccine for meningitis B has shown favourable results in two phase III trials. ... Trumenba was approved by the FDA in 2014 to prevent invasive meningococcal disease caused by Neisseria meningitides serogroup B.

  • Pfizer gets FDA nod for meningitis vaccine Trumenba Pfizer gets FDA nod for meningitis vaccine Trumenba

    Trumenba - formerly known as rLP2086 - has been approved by the FDA to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in people aged 10 to 25, a strain which ... Invasive meningococcal disease is a life-threatening

  • US panel backs pneumococcal vaccines for seniors US panel backs pneumococcal vaccines for seniors

    The ACIP recommendations now go to the Centers for Disease Control and Prevention (CDC) and Department of Health and Human Services (DHHS) for review and approval. ... Separately, Pfizer also said that the FDA has accepted its marketing application for

  • Pfizer's meningitis vaccine 'a breakthrough' Pfizer's meningitis vaccine 'a breakthrough'

    Aside from the risk of death, meningococcal B disease can also lead to long-term disabilities such as brain damage and hearing loss. ... The breakthrough therapy designation highlights the urgent need for prevention of meningococcal B disease," he added.

  • Research into meningococcal B disease Research into meningococcal B disease

    Research into meningococcal B disease. The first approved vaccine represents a major success for meningococcal B research efforts. ... Looking ahead. Vaccines against serotype B meningococcal disease have proved difficult to produce, and require a

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
WCG

WCG is an independent, global agency specialising in healthcare communications. Our value as a company is about being the positive...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics